|
"tseng l m"的相关文件
显示项目 56-61 / 61 (共3页)
<< < 1 2 3
每页显示[10|25|50]项目
| 國立臺灣大學 |
2016 |
First-line ribociclib plus letrozole in postmenopausal Asian women with hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): A subgroup analysis from MONALEESA-2
|
Yap, Y. S.; Tseng, L-M.; Blackwell, K. L.; Cameron, D.; Foo, S.; Sriuranpong, V.; Huang, C-S.; Chao, T-Y.; Kim, T-Y.; Chen, S-C.; Jung, K. H.; Lee, K. S.; Sohn, J-H.; Kim, J. H.; Hou, M-F.; Han, Y.; Souami, F.; Dhuria, S.; Miller, M.; Verma, S.; 黃俊升 |
| 國立臺北護理健康大學 |
2015 |
The impact of pain on the quality of life of Taiwanese oncology patients
|
Liang, S.Y.; Wu, S.F.; Chao, T.C.; Tseng, L.M.; Wu, W.W.; Wang, T.J.; Lu, Y.Y. |
| 臺大學術典藏 |
2015 |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Cheng A.-L.; Shih T.T.-F.; CHIUN-SHENG HUANG; Huang S.-M.; Chao T.-C.; Chen B.-B.; Rau K.-M.; Lu Y.-S.; Chen T.W.-W.; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Taiwan Breast Cancer Consortium |
| 國立臺灣大學 |
2013 |
Distant metastasis in triple-negative breast cancer
|
Tseng, L. M.; Hsu, N. C.; Chen, S. C.; Lu, Y. S.; Lin, C. H.; Chang, D. Y.; Li, H.; Lin, Y. C.; Chang, H. K.; Chao, T. C.; Ouyang, F.; Hou, M. F.; 盧彥伸; 張端瑩; 林璟宏 |
| 臺大學術典藏 |
2011 |
Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
|
Lu Y.-S.;Chen D.-R.;Tseng L.-M.;Yeh D.-C.;Chen S.-T.;Hsieh C.-M.;Wang H.-C.;Yeh H.-T.;Kuo S.-H.;Chiun-Sheng Huang; Lu Y.-S.; Chen D.-R.; Tseng L.-M.; Yeh D.-C.; Chen S.-T.; Hsieh C.-M.; Wang H.-C.; Yeh H.-T.; Kuo S.-H.; CHIUN-SHENG HUANG |
| 國立臺灣大學 |
2006 |
IDN reverse proxy for transparent internationalized domain name resolution
|
Lin, Jeng-Wei; Ho, Jan-Ming; Tseng, L-M.; Lai, Feipei |
显示项目 56-61 / 61 (共3页)
<< < 1 2 3
每页显示[10|25|50]项目
|
